The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study
Abstract
A longitudinal study of asymptomatic individuals at risk of autosomal dominant familial Alzheimer's disease was performed to assess the earliest clinical and neuropsychological features of the disease. Over a 6-year period, 63 subjects underwent serial assessments. During the study, 10 subjects developed symptoms of episodic memory loss and subsequently progressed to fulfil criteria for possible or probable Alzheimer's disease. The mean time (+/-SD) from first assessment to the appearance of symptoms was 2.6+/-1.4 years. The subjects who remained well were similar to those who became clinically affected in terms of age, family history and initial Mini-Mental State Examination. Individuals who later became clinically affected already had significantly lower verbal memory (P=0.003) and performance IQ (P=0.030) scores at their first assessment, when they were ostensibly unaffected. Subsequent assessments showed progressive decline in multiple cognitive domains. Blinded assessment of serial imaging revealed the appearance of diffuse cerebral and medial temporal lobe atrophy in subjects only once they were clinically affected. These findings imply that in familial Alzheimer's disease cognitive decline predates symptoms by several years and that verbal memory deficits precede more widespread deterioration. This may have implications for the detection and treatment of Alzheimer's disease at an early stage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
Amyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370 · cited 2×
“Pedigrees with an autosomal dominant pattern of inheritance of Alzheimer’s disease have been recognized for many years, and recently three genetic loci responsible for early-onset disease (before the age of 65 years) have been described (Hardy, 1997).”
BackgroundReiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
Mild cognitive impairment in the elderly: Predictors of dementia
Flicker, C., Ferris, S. H., & Reisberg, B. (1991) · Neurology · doi:10.1212/wnl.41.7.1006 · Cited by 838
Presymptomatic hippocampal atrophy in Alzheimer's disease: A longitudinal MRI study
Fox, N. C., Warrington, E. K., Freeborough, P. A., Hartikainen, P., Kennedy, A. M., Stevens, J. M., & Rossor, M. N. (1996) · Brain · doi:10.1093/brain/119.6.2001 · Cited by 656
Self-citationTierney, M. C., Szalai, J. P., Snow, W. G., Fisher, R. H., Nores, A., Nadon, G., Dunn, E., & St. George-Hyslop, P. H. (1996) · Neurology · doi:10.1212/wnl.46.3.661 · Cited by 575
A POST-MORTEM STUDY OF THE CHOLINERGIC AND GABA SYSTEMS IN SENILE DEMENTIA
ROSSOR, M. N., GARRETT, N. J., JOHNSON, A. L., MOUNTJOY, C. Q., ROTH, M., & IVERSEN, L. L. (1982) · Brain · doi:10.1093/brain/105.2.313 · Cited by 460
Progression to dementia in patients with isolated memory loss
Bowen, J., Teri, L., Kukull, W., McCormick, W., McCurry, S. M., & Larson, E. B. (1997) · The Lancet · doi:10.1016/s0140-6736(96)08256-6 · Cited by 310
Cited by
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease
Bartzokis, G. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.03.001 · Cited by 968
Scahill, R. I., Schott, J. M., Stevens, J. M., Rossor, M. N., & Fox, N. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052587399 · Cited by 764
Self-citationCerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study
Ruitenberg, A., den Heijer, T., Bakker, S. L. M., van Swieten, J. C., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2005) · Annals of Neurology · doi:10.1002/ana.20493 · Cited by 733
The diagnosis of young-onset dementia
Rossor, M. N., Fox, N. C., Mummery, C. J., Schott, J. M., & Warren, J. D. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70159-9 · Cited by 586
Self-citationDiffering patterns of temporal atrophy in Alzheimer's disease and semantic dementia
Galton, C. J., Patterson, K., Graham, K., Lambon-Ralph, M. A., Williams, G., Antoun, N., Sahakian, B. J., & Hodges, J. R. (2001) · Neurology · doi:10.1212/wnl.57.2.216 · Cited by 582
Bateman, R. J., Aisen, P. S., De Strooper, B., Fox, N. C., Lemere, C. A., Ringman, J. M., Salloway, S., Sperling, R. A., Windisch, M., & Xiong, C. (2010) · Alzheimer's Research & Therapy · doi:10.1186/alzrt59 · Cited by 573
Self-citationCholinesterase inhibitors: new roles and therapeutic alternatives
GIACOBINI, E. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2003.11.017 · Cited by 555
Language performance in Alzheimer's disease and mild cognitive impairment: A comparative review
Taler, V., & Phillips, N. A. (2008) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390701550128 · Cited by 529
Advances in the early detection of Alzheimer's disease
Nestor, P. J., Scheltens, P., & Hodges, J. R. (2004) · Nature Medicine · doi:10.1038/nrn1433 · Cited by 463
Fox, N. C., Crum, W. R., Scahill, R. I., Stevens, J. M., Janssen, J. C., & Rossor, M. N. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05408-3 · Cited by 455
Self-citationStability of the preclinical episodic memory deficit in Alzheimer's disease
Bäckman, L., Small, B. J., & Fratiglioni, L. (2001) · Brain · doi:10.1093/brain/124.1.96 · Cited by 449
Neuroplasticity Failure in Alzheimer's Disease
Mesulam, M.-M. (1999) · Neuron · doi:10.1016/s0896-6273(00)81109-5 · Cited by 449
Swainson, R., Hodges, J. R., Galton, C. J., Semple, J., Michael, A., Dunn, B. D., Iddon, J. L., Robbins, T. W., & Sahakian, B. J. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051269 · Cited by 375
The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment
Collie, A., & Maruff, P. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00012-9 · Cited by 335
Small, B. J., Fratiglioni, L., Viitanen, M., Winblad, B., & Bäckman, L. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.839 · Cited by 329
Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study
Ridha, B. H., Barnes, J., Bartlett, J. W., Godbolt, A., Pepple, T., Rossor, M. N., & Fox, N. C. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70550-6 · Cited by 326
Self-citationLongitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease
McDade, E., Wang, G., Gordon, B. A., Hassenstab, J., Benzinger, T. L. S., Buckles, V., Fagan, A. M., Holtzman, D. M., Cairns, N. J., Goate, A. M., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000006277 · Cited by 314
Self-citationMultiple cognitive deficits during the transition to Alzheimer's disease
Bäckman, L., Jones, S., Berger, A. ‐., Laukka, E. J., & Small, B. J. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01386.x · Cited by 291
Differentiating frontal and temporal variant frontotemporal dementia from Alzheimer’s disease
Perry, R. J., & Hodges, J. R. (2000) · Neurology · doi:10.1212/wnl.54.12.2277 · Cited by 284
Rusinek, H., De Santi, S., Frid, D., Tsui, W.-H., Tarshish, C. Y., Convit, A., & de Leon, M. J. (2003) · Radiology · doi:10.1148/radiol.2293021299 · Cited by 281
“In unaffected subjects genetically at risk for early-onset AD, whole-brain atrophy measured at magnetic resonance (MR) imaging was predictive of decline to AD (18,19).”
BackgroundNeuropsychological and neuroimaging changes in preclinical Alzheimer's disease
TWAMLEY, E. W., ROPACKI, S. A. L., & BONDI, M. W. (2006) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617706060863 · Cited by 273
Acosta-Baena, N., Sepulveda-Falla, D., Lopera-Gómez, C. M., Jaramillo-Elorza, M. C., Moreno, S., Aguirre-Acevedo, D. C., Saldarriaga, A., & Lopera, F. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70323-9 · Cited by 263
DE JAGER, C. A., HOGERVORST, E., COMBRINCK, M., & BUDGE, M. M. (2003) · Psychological Medicine · doi:10.1017/s0033291703008031 · Cited by 259
“Our finding that most AD cases had both verbal and visual memory deficits suggests that hippocampal volume loss is bilateral (Fox et al. 1998; Petersen et al. 2000), but certain subjects may be able to compensate for either verbal or visuospatial memory deficits in the preclinical stages.”
BackgroundMuhammad, A., Flores, I., Zhang, H., Yu, R., Staniszewski, A., Planel, E., Herman, M., Ho, L., Kreber, R., Honig, L. S., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802545105 · Cited by 248
Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration
Weston, P. S. J., Poole, T., Ryan, N. S., Nair, A., Liang, Y., Macpherson, K., Druyeh, R., Malone, I. B., Ahsan, R. L., Pemberton, H., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004667 · Cited by 245
Self-citationVascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia.
Román, G. C., & Kalaria, R. N. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.004 · Cited by 213
Sunderland, T., Mirza, N., Putnam, K. T., Linker, G., Bhupali, D., Durham, R., Soares, H., Kimmel, L., Friedman, D., Bergeson, J., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.021 · Cited by 179
Correlating familial Alzheimer’s disease gene mutations with clinical phenotype
Ryan, N. S., & Rossor, M. N. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.09.92 · Cited by 176
A systematic literature review of automatic Alzheimer’s disease detection from speech and language
Petti, U., Baker, S., & Korhonen, A. (2020) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa174 · Cited by 168
Dominantly Inherited Alzheimer Network: facilitating research and clinical trials
Moulder, K. L., Snider, B., Mills, S. L., Buckles, V. D., Santacruz, A. M., Bateman, R. J., & Morris, J. C. (2013) · Alzheimer's Research & Therapy · doi:10.1186/alzrt213 · Cited by 142
Stress‐induced hyperphosphorylation of tau in the mouse brain
Okawa, Y., Ishiguro, K., & Fujita, S. C. (2003) · FEBS Letters · doi:10.1016/s0014-5793(02)03883-8 · Cited by 98
Behavior and Treatment in Frontotemporal Dementia
Perry, R. J., & Miller, B. L. (2001) · Neurology · doi:10.1212/wnl.56.suppl_4.s46 · Cited by 90
Borba, E. M., Duarte, J. A., Bristot, G., Scotton, E., Camozzato, A. L., & Chaves, M. L. F. (2016) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000450601 · Cited by 67
The contribution of the study of neurodegenerative disorders to the understanding of human memory
Panegyres, P. K. (2004) · QJM · doi:10.1093/qjmed/hch096 · Cited by 60
Clinical, biological, and imaging features of monogenic Alzheimer’s disease
Pilotto, A., Padovani, A., & Borroni, B. (2013) · BioMed Research International · doi:10.1155/2013/689591 · Cited by 47
Metadata
- Authors
- Fox, N.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-09-01
- Volume
- 121
- Issue
- 9
- Pages
- 1631-1639
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2111709425
- Cited by
- 262
- References
- 24
- FWCI
- 9.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.